UW-Madison Launches New Ophthalmology Tissue Biobank
Nov 30 2022
The University of Wisconsin Department of Ophthalmology and Visual Sciences (DOVS) has entered into a new partnership aimed at systematically collecting, storing, processing and distributing human eye tissue for research purposes.
Read MoreA20 Attenuates the Fibrotic Response in the Trabecular Meshwork.
Feb 09 2022
PubMed ID: 35216043 Author(s): Mzyk P, Zalog EG, McDowell CM. A20 Attenuates the Fibrotic Response in the Trabecular Meshwork. Int J Mol Sci. 2022 Feb 9;23(4). pii: 1928. doi: 10.3390/ijms23041928. PMID 35216043 Journal: International Journal…
Read MoreConsensus Recommendation for Mouse Models of Ocular Hypertension to Study Aqueous Humor Outflow and Its Mechanisms.
Feb 01 2022
PubMed ID: 35129590 Author(s): McDowell CM, Kizhatil K, Elliott MH, Overby DR, van Batenburg-Sherwood J, Millar JC, Kuehn MH, Zode G, Acott TS, Anderson MG, Bhattacharya SK, Bertrand JA, Borras T, Bovenkamp DE, Cheng L,…
Read MoreCaffeine Inhibits Choroidal Neovascularization Through Mitigation of Inflammatory and Angiogenesis Activities.
Jan 01 2021
PubMed ID: 34722519 Author(s): Sorenson CM, Song YS, Zaitoun IS, Wang S, Hanna BA, Darjatmoko SR, Gurel Z, Fisk DL, McDowell CM, McAdams RM, Sheibani N. Caffeine Inhibits Choroidal Neovascularization Through Mitigation of Inflammatory and…
Read MoreFibronectin extra domain A (FN-EDA) elevates intraocular pressure through Toll-like receptor 4 signaling.
Jun 17 2020
PubMed ID: 32555351 Author(s): Roberts AL, Mavlyutov TA, Perlmutter TE, Curry SM, Harris SL, Chauhan AK, McDowell CM. Fibronectin extra domain A (FN-EDA) elevates intraocular pressure through Toll-like receptor 4 signaling. Sci Rep. 2020 Jun…
Read MoreEffects of Toll-Like Receptor 4 Inhibition on Transforming Growth Factor-β2 Signaling in the Human Trabecular Meshwork.
Apr 01 2020
PubMed ID: 31834824 Author(s): Sharma TP, Curry S, McDowell CM. Effects of toll-like receptor 4 inhibition on transforming growth factor-β2 signaling in the human trabecular meshwork. J Ocul Pharmacol Ther. 2020 Apr;36(3):170-178. doi: 10.1089/jop.2019.0076. Epub…
Read MoreNuclear factor-kappa beta signaling is required for transforming growth factor Beta-2 induced ocular hypertension.
Feb 01 2020
PubMed ID: 31923415 Author(s): Hernandez H, Roberts AL, McDowell CM. Nuclear factor-kappa beta signaling is required for transforming growth factor Beta-2 induced ocular hypertension. Exp Eye Res. 2020 Feb;191:107920. doi: 10.1016/j.exer.2020.107920. Epub 2020 Jan 8.…
Read MoreDisruption of fibronectin fibrillogenesis affects intraocular pressure (IOP) in BALB/cJ mice.
Jan 01 2020
PubMed ID: 32822410 Author(s): Faralli JA, Filla MS, McDowell CM, Peters DM. Disruption of fibronectin fibrillogenesis affects intraocular pressure (IOP) in BALB/cJ mice. PLoS One. 2020 Aug 21;15(8):e0237932. doi: 10.1371/journal.pone.0237932. eCollection 2020. PMID 32822410 Journal:…
Read MoreEffect of ocular hypertension on the pattern of retinal ganglion cell subtype loss in a mouse model of early-onset glaucoma.
Aug 01 2019
PubMed ID: 31211954 Author(s): Daniel S, Meyer KJ, Clark AF, Anderson MG, McDowell CM. Effect of ocular hypertension on the pattern of retinal ganglion cell subtype loss in a mouse model of early-onset glaucoma. Exp…
Read More